Oncolytics Biotech (ONCY) Return on Capital Employed [ROCE] (2009 - 2026)
Oncolytics Biotech's Return on Capital Employed [ROCE] came in at -1254.89% for Q2 2026, down 1015.78 percentage points from -239.11% a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, Oncolytics Biotech's Return on Capital Employed [ROCE] was -652.77%, down 495.16 percentage points from FY2024.
- Return on Capital Employed [ROCE] has declined in each of the last three years, with a five-year change of -548.37 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -157.61% in FY2024 (-59.79 pp), -97.82% in FY2023 (-27.92 pp), -69.90% in FY2022 (+2.35 pp) and -72.24% in FY2021 (+32.15 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2009.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2021 (a gain of 15.06 percentage points), and the weakest in Q2 2026 (a drop of 1015.78 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 11.86% |
| 10 | Oncolytics Biotech | 62.32 Mn | 33.44 Mn | - | -1,265.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,265.84% |
| Sep 30, 2025 | -388.51% |
| Jun 30, 2025 | -240.62% |
| Dec 31, 2024 | -183.32% |
| Sep 30, 2024 | -149.80% |
| Jun 30, 2024 | -104.72% |
| Dec 31, 2023 | -77.17% |
| Sep 30, 2023 | -103.79% |
| Jun 30, 2023 | -88.47% |
| Dec 31, 2022 | -83.92% |
| Sep 30, 2022 | -68.71% |
| Jun 30, 2022 | -67.39% |
| Dec 31, 2021 | -63.09% |
| Sep 30, 2021 | -53.34% |
| Jun 30, 2021 | -54.73% |
| Dec 31, 2020 | -76.67% |
| Sep 30, 2020 | -63.49% |
| Jun 30, 2020 | -60.71% |
| Sep 30, 2019 | -88.16% |
| Jun 30, 2019 | -27.25% |
API Access
Oncolytics Biotech Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();